Akamatsu Naoki, Tsuji Sadatoshi
Department of Neurology, University of Occupational and Environmental Health, School of Medicine, Iseigaoka, Yahatanishi-ku, Kitakyusyu, Japan.
Brain Nerve. 2011 Apr;63(4):309-12.
Many guidelines for the management of epilepsy have been published since the introduction of evidence-based medicine. In Japan, the first clinical guideline for epilepsy management was published by the Japanese Society of Neurology (JSN) in 2002. The Japan Epilepsy Society (JES) has been publishing guidelines for several topics since 2005. However, owing to recent advances in epileptology and the accumulation of related knowledge, it has become necessary to revise these guidelines. Four medical societies-JSN, JES, the Japanese Society of Neurological Therapeutics, and the Japanese Society of Child Neurology-have together published new epilepsy-related clinical guidelines for practitioners. The guideline committee consists of 23 specialists representing the 4 societies. The guidelines primary target general practitioners treating epilepsy patients and are designed to be user friendly-in the form of 81 "clinical questions" (CQs). The CQs comprehensively cover various aspects of epilepsy management including those related to diagnosis, treatment, surgery, pregnancy, and social issues. Recommendations are concisely described with levels from A to D. The evidence level (I to IV) of the references is based on the literature review conducted by the committee. These guidelines were published in October 2010.
自循证医学引入以来，已经发布了许多癫痫管理指南。在日本，日本神经学会（JSN）于2002年发布了首部癫痫管理临床指南。自2005年以来，日本癫痫学会（JES）一直在发布关于多个主题的指南。然而，由于近年来癫痫学的进展以及相关知识的积累，修订这些指南变得必要。日本神经学会、日本癫痫学会、日本神经治疗学会和日本儿童神经学会这四个医学学会共同为从业者发布了新的癫痫相关临床指南。指南委员会由代表这四个学会的23名专家组成。该指南的主要目标是治疗癫痫患者的全科医生，并且设计得便于使用——采用81个“临床问题”（CQs）的形式。这些临床问题全面涵盖了癫痫管理的各个方面，包括与诊断、治疗、手术、妊娠和社会问题相关的方面。推荐意见以A到D级简洁描述。参考文献的证据级别（I至IV）基于委员会进行的文献综述。这些指南于2010年10月发布。
